The tumor suppressor and transcription factor p53 plays a key role in cell cycle regulation, apoptosis and senescence and is frequently inactivated in human tumors. Nanobodies against p53 are generated and characterized, in vitro and in vivo. These nanobodies are subsequently utilized to manipulate the activity of p53 in cells in terms of intracellular localization and activity.